License: Creative Commons Attribution 4.0 PDF - Published Version (12MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-554076
- DOI to cite this document:
- 10.5283/epub.55407
Abstract
Although significant improvements have been made in the treatment of pancreatic cancer, its prognosis remains poor with an overall 5-year survival rate of less than 10%. New experimental approaches are necessary to develop novel therapeutics. In this study, the investigation of pancreatic cancer tissue growth in the chorioallantoic membrane (CAM) model and the subsequent use of indocyanine green ...
Owner only: item control page